Assessing Whether CME Group (CME) Looks Undervalued After Recent Share Price Weakness

Recent performance snapshot for CME Group (CME)

CME Group (CME) has attracted fresh attention after a stretch of weaker share performance, with the stock down 3% over the past day, 11% over the past week, and 13% over the past month.

See our latest analysis for CME Group.

At the current share price of US$250.53, CME Group’s recent 30 day share price return has weakened alongside a softer 90 day move, even though the 3 year and 5 year total shareholder returns remain firmly positive.

If you are reassessing your watchlist after CME Group’s pullback, this could be a useful moment to broaden your search and uncover 20 top founder-led companies

With CME Group’s share price under pressure despite positive multi year returns and current earnings in the black, the real question is whether this pullback hints at value or if the market is already pricing in future growth?

Most Popular Narrative: 18.3% Undervalued

Based on the most followed narrative, CME Group’s fair value of $306.60 sits well above the last close of $250.53, raising a clear valuation gap for you to weigh.

The ongoing global shift toward electronic trading, greater regulatory demands for transparency and standardized clearing, and a proven ability to grow non transactional revenue (e.g., record market data revenue) position CME to capture a larger share of trading activity and support durable long term earnings growth.

Read the complete narrative.

Want the full story behind that price gap? The narrative hinges on steady revenue expansion, high margins, and a future earnings multiple that assumes real staying power.

Result: Fair Value of $306.60 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this relies on steady trading activity. Lower volatility or rising competition from lower fee or decentralized venues could quickly challenge those assumptions.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Another View: Market Multiple Signals Caution

That 18.3% undervaluation narrative sits awkwardly beside CME Group’s current P/E of 21.4x, which screens as expensive against an estimated fair ratio of 15.9x. In simple terms, the share price already embeds a richer multiple, so the real risk may be that expectations, not earnings, are doing more of the work.

For a closer look at how this P/E gap compares with the US Capital Markets industry average of 39.5x and a peer average of 26x, and what that might mean for future repricing risk or opportunity, See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With sentiment clearly mixed, this is a good time to look past headlines, weigh the balance of risks and rewards, and decide where you stand by using 3 key rewards and 2 important warning signs

Looking for more investment ideas?

If CME Group has you reassessing your next move, do not stop here, broaden your opportunity set now so you do not miss stocks that better fit your goals.

• Target resilient income by reviewing companies in the 11 dividend fortresses that prioritize substantial yields supported by established businesses.
• Hunt for potential upside with the screener containing 22 high quality undiscovered gems, highlighting underfollowed stocks that pair quality fundamentals with room to gain attention.
• Dial down portfolio risk by scanning 63 resilient stocks with low risk scores that combine steadier fundamentals with lower risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com